MENU

Leading brokers name 3 ASX shares to buy today

Brokers up and down Australia have been busy adjusting their estimates and discounted cash flow models again this week.

This has led to a number of broker notes being released. Three buy ratings that caught my eye are summarised below. Here’s why brokers are bullish on them:

Aristocrat Leisure Limited (ASX: ALL)

According to a note out of Deutsche Bank, its analysts have retained their buy rating and $39.75 price target on this gaming technology company’s shares following the release of the full year result of rival International Game Technology late last week. The broker believes that its result and guidance demonstrate that the North American market is stable and that Aristocrat Leisure is winning market share. I agree with Deutsche on Aristocrat Leisure and feel it would be a great investment option.

IPH Ltd (ASX: IPH)

A note out of the Macquarie equities desk reveals that its analysts have upgraded this intellectual property services company’s shares to an outperform rating with an increased price target of $7.10. According to the note, the broker believes IPH is in a strong position in the fight to merge with Xenith IP Group Ltd (ASX: XIP). If this does go ahead, instead of with QANTM Intellectual Property Ltd (ASX: QIP), the broker sees significant accretion potential. I think Macquarie makes a good point on IPH and it could be worth a look.

Nufarm Limited (ASX: NUF)

Analysts at Goldman Sachs have upgraded this crop protection and seeds technology company’s shares to a buy rating with a $6.90 price target. According to the note, the broker made the move after its shares lost almost a third of their value over the last 12 months. In addition to this, Goldman believes Nufarm is well positioned to benefit from an improving industry backdrop and shifting business mix.  The broker expects measured growth from here and believes concerns over Australia and glyphosate are overdone. Whilst I’m not a big fan of Nufarm, I agree that its shares look good value at this level.

Analyst Names 3 Growth Shares to Buy in March

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked...

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2019."

Each one pays a fully franked dividend. The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies move – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended IPH Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!